Product Description
Bravecto 1000 mg Chewable Tablet for Large Dogs (20–40 kg)
Product Overview
Bravecto is a veterinary prescription (POM-V) chewable tablet for large dogs weighing between 20 kg and 40 kg . Manufactured by MSD Animal Health (Merck Animal Health), it provides long-lasting protection against fleas, ticks, and mites with a single dose .
Key Specifications
Key Benefits
Indications for Use
Bravecto is indicated for the treatment and prevention of:
Additional Indications:
-
Can be used as part of a treatment strategy for Flea Allergy Dermatitis (FAD)
-
Reduces the risk of Babesia canis (babesiosis) transmission by ticks
-
Reduces the risk of Dipylidium caninum (tapeworm) transmission by fleas
Dosage and Administration
| Dog Weight | Tablet Strength |
|---|---|
| 2 – 4.5 kg | 112.5 mg (Miniature) |
| > 4.5 – 10 kg | 250 mg (Small) |
| > 10 – 20 kg | 500 mg (Medium) |
| 20 – 40 kg | 1000 mg (Large) |
| > 40 – 56 kg | 1400 mg (Extra-Large) |
Administration Instructions:
-
Administer orally at or around the time of feeding for maximum effectiveness
-
Can be mixed with food or given by hand as it is highly palatable
-
Dogs over 56 kg should receive a combination of tablets that most closely matches body weight
Safety Information
Contraindications:
-
Do not use in puppies less than 8 weeks of age or weighing less than 2 kg
-
Do not use in case of hypersensitivity to fluralaner or any excipients
Warnings and Precautions:
-
Do not administer at intervals shorter than 8 weeks as safety for shorter intervals has not been tested
-
Fleas and ticks must attach to the host and commence feeding to be exposed to the active substance
-
For dogs infected with tapeworm, it is recommended that a suitable tapeworm treatment be used
-
Keep the product in the original packaging until use


